Delivery Order SPE2DB22D2211-SPE2DB24FMSA0
Award Date 1/29/24
Potential Completion Date 1/30/24
Potential Value $5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Advair HFA 230-21 MCG inhalers valued at $16,227.10. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
- The Defense Logistics Agency (DLA) awarded a $4,866.80 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,248,106 units of the Advair HFA 115-21 MCG inhaler (12 gram). This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA Troop Support Medical, valued at up to $999,999,999.00 and effective through December 31, 2025. The IDC serves as the...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the federal government. The $1,586.59 firm fixed-price contract is for the delivery of the pharmaceutical product Advair HFA 45-21 mcg Inhaler 12GM. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,862.36 to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The contract is for the delivery of Advair HFA 230-21 MCG inhalers to support military treatment programs and facilities. The delivery order was issued under an existing indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, which has a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of pharmaceutical products. Specifically, the contract is for the delivery of Advair HFA 230-21 MCG inhalers, with a ceiling value of $10,761.84 and a period of performance through April 4, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) with a potential value of...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $17,942.06, is for the supply of Advair HFA 230-21 MCG inhalers to support military medical treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp, valued at up to...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $3,549.84 to Amerisourcebergen Drug Corp, a leading pharmaceutical distribution company, for the provision of Advair HFA 230-21 MCG Inhaler 12GM. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to supply a comprehensive range of pharmaceutical products and medical supplies to military...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order valued at $5,393.88 to Amerisourcebergen Drug Corp, a leading global pharmaceutical distributor, for the provision of Advair HFA 115-21 mcg inhalers. This delivery order, with a period of performance through April 2, 2024, is issued under an indefinite delivery contract (IDC) with a potential value of up to $999,999,999.00 that enables Amerisourcebergen to deliver a comprehensive range of pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $6,431.62 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of Advair HFA 230-21 MCG Inhaler 12GM, a pharmaceutical product, with a performance period through April 11, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded by DLA to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Advair HFA 45-21 mcg inhalers. The $2,706.60 contract has an ultimate completion date of April 1, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB24FMSA0Delivery Order
The Defense Logistics Agency (DLA) awarded a $5,031.24 firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, for the supply of Advair HFA 230-21 MCG inhalers. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract has a performance period through December 31, 2025 and does not have a set-aside designation.
Generated 4/29/24, 9:51 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 1/29/24 |